Vlado, agree, what i think will be helpful would be an approximate timeline for validation of the RUO Bard1 kit for Ovarian Ca from Griffith Uni, and given that the Uni of Geneva have validated the kit and we know it works on the Luminex platform it hopefully won't be a long process, we then need to know how long to commercialisation for kit sales, this would provide improved SH confidence in the Co.
Ann: Notice of Annual General Meeting/Proxy Form, page-12
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
58.5¢ |
Change
0.020(3.54%) |
Mkt cap ! $64.51M | |||
| Open | High | Low | Value | Volume |
| 57.0¢ | 58.5¢ | 56.5¢ | $3.293K | 5.744K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 57.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 58.5¢ | 8303 | 1 |
View Market Depth
| Last trade - 12.53pm 09/08/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |